Trial Profile
Assessment and Prediction of Cetuximab-Induced Hypersensitivity Reactions Using Cetuximab Specific IgE Detection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer; Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions
- 05 Apr 2018 New trial record